Aims Lipoproteins and lipids, especially lipoprotein(a), have been studied as risk factors for restenosis after coronary angioplasty with conflicting results. We investigated the association between serum levels of lipoprotein(a) apolipoprotein A-1, apolipoprotein B-100, totalcholesterol, high density lipoprotein-cholesterol, triglycerides, and coronary luminal loss and restenosis after angioplasty.
Introduction
Abnormal plasma levels of lipoprotein(a) [Lp(a)], apolipoprotein A-1 (apoA), apolipoprotein B-100 (apoB), total cholesterol, high density lipoprotein cholesterol (HDL-cholesterol) and triglycerides have been associated with the development and progression of coronary artery disease [1] [2] [3] [4] [5] [6] . On the basis of their atherogenic features, the lipoproteins and lipids have been studied as possible risk factors for restenosis after angioplasty.
Much attention has been paid to Lp(a), and increased concentrations have been associated with restenosis [7] [8] [9] [10] , while other studies have shown contradictory results [5, [11] [12] [13] . Assessment of apoA, ApoB, total cholesterol, high density lipoprotein and triglycerides due to their correlation with Lp(a) [14] [15] [16] have also been taken into account in these studies, with lack of unequivocal results.
A categorical approach, which defines angiographic restenosis as a dichotomous outcome, has mostly been used to describe the relationship between lipoproteins, lipids and restenosis. The luminal renarrowing postinterventionally has been demonstrated to be a normally distributed continuous phenomenon [17] . Late loss in luminal diameter reflects the time-related anatomical change of the lesions after angioplasty, and is a better representation of the pathological process leading to restenosis than the categorical dichotomous approach
The main purpose of this study was to investigate the relationship between late loss in luminal diameter after percutaneous translumial coronary angioplasty (PTCA) and plasma levels of Lp(a) as the primary focus, and apoA, apoB, total cholesterol, high density lipoprotein and triglycerides. Secondly, we explored their possible role as risk factors for restenosis.
Methods

Patients
Lipoproteins and lipids were analysed in 384 consecutive patients below 70 years of age with stable angina pectoris and no myocardial infarction within the last 3 months. All patients had de-novo stenosis in one or more of the major native coronary arteries suitable for balloon angioplasty. The study was prospective and part of the Coronary Angioplasty Amlodipine Restenosis Study (CAPARES) [20] . Since the study drug amlodipine did not influence luminal loss or the incidence of restenosis after PTCA [21] , all patients were pooled in the present study. Patients in whom the angioplasty was unsuccessful, received coronary stents, or did not undergo follow-up angiography suitable for quantitative coronary analysis were excluded. A total of 305 patients constituted the final study population. All patients gave written informed consent to the study, which was carried out in according with the declaration of Helsinki, and approved by the local ethics committee.
Lipoprotein and lipids measurements
Blood samples were drawn from the cubital vein after a 12 h overnight fast before PTCA. The plasma concentrations of Lp(a), apoA, apoB, HDL-cholesterol, total cholesterol and triglycerides were analysed by single laboratories using commercially available kits. Lp(a) was stored frozen ( 18 C), and measured within 7 days using nephelometry (Behring Diagnostic, Germany). ApoA and apoB were measured using turbidimetry (Behringwerke, Marburg, Germany) and total cholesterol, HDL-cholesterol, and triglycerides using enzymatic colometry (Boehringer-Mannheim, Mannheim, Germany). The latter samples were stored frozen ( 80 C, <6 months).
Angioplasty and coronary measurements
Angioplasty was performed according to standard techniques. Aspirin and calcium channel blockers were given prior to angioplasty, and heparin during the procedure to all patients. The choice of balloon type, pressure and duration of inflation was decided by the operator. Follow-up angiography was performed 20 3 weeks after angioplasty. In order to achieve the same vascular tone at angioplasty and reangiography, the same calcium channel blockers were given for both procedures. For the purpose of coronary quantitative analysis, two near orthogonal views which best showed the lesion were obtained before PTCA. The settings of the X-ray equipment were recorded for each patient, to ensure that exactly the same angiographic projections were used before and after angioplasty, and at followup. Quantitative coronary angiography was done as previously described [22, 23] , using the Cardiovascular Angiography Analysis System (CAAS II) (Pie Medical Imaging, Maastricht, Netherlands). The tip of the catheters were used as a scaling device.
Angiographic variables and definitions
For each dilated lesion the average of the measurements from more than one view per lesion was used, and for patients who had more than one dilated lesion, the average measurement of all lesions per patient was used. Gain was defined as minimal lumen diameter immediately after PTCA minus minimal lumen diameter pre-PTCA, and loss in luminal diameter as minimal lumen diameter immediately after PTCA minus minimal lumen diameter at follow-up. To control for the influence of different reference diameters of the vessels, luminal gain and loss were divided by the computer-calculated interpolated reference diameter of the vessel measured before angioplasty (relative gain, relative loss) [19, 24] , when applied to the continuous approach. Restenosis was defined according to three categorical criteria: (1) >50% diameter stenosis at follow-up; (2) loss of >50% of the gain; (3) the clinically driven need for target vessel revascularization (either repeat PTCA or coronary bypass grafting) after successful PTCA [25] . With regards to the categorical approach, only patients with single lesion dilatation were studied, because the average value from two or more lesions may interfere with the categorical cut-off point based on a per-lesion assessment.
Statistics
Comparing variables between restenosis and norestenosis groups was done using t-test for normally distributed variables, Mann-Whitney U test for skewed variables and Fisher's exact test for categorical variables. Multiple linear regression analysis was employed to explore the correlation between relative luminal loss after angioplasty (as the dependent variable) and the lipoproteins and lipids (as independent variables). Univariate and stepwise multivariate logistic regression models were used to identify possible independent predictors of restenosis according to the three categorical definitions separately. Potential confounding of clinical and angiographic variables previously shown to be associated with luminal loss or restenosis were also entered as independent variables [26] [27] [28] . The lipoprotein and lipid variables were divided into quartiles for comparison of luminal loss between the lowest and highest quartiles. ANOVA post hoc analysis with Bonferroni correction (P level at 0·0083) was used. The variables showing skewed distributions (Lp(a), apoB and triglycerides) were log-transformed, and dichotomous categorical variables were coded as 0 or 1, when incorporated in the regression analyses. The strength of the associations with restenosis is presented as odds ratios (OR) with 95% confidence intervals (CI). Data are presented as mean SD for normally distributed variables, median (range) for skewed variables, and number (percentage) for categorical variables.
Results
Baseline characteristics of the 305 patients are shown in Table 1 . There were no significant differences in baseline variables between the restenosis and no-restenosis groups according to the three definitions. The angiographic results from the quantitative coronary analysis are shown in Table 2 . Single vessel dilatation was done in 251 patients (82·3%). There were no significant differences between the restenosis and no-restenosis groups for Lp(a) or any of the other lipoproteins and lipids assessed (Table 3) .
Relationship between luminal loss and the lipoproteins and lipids
Univariate regression analysis did not reveal significant associations between relative luminal loss and the serum levels of Lp(a) (P=0·95), apoA (P=0·10), apoB (P=0·16), total cholesterol (P=0·37), high density lipoprotein (P=0·70) or triglycerides (P=0·15), respectively. When we compared luminal loss between the highest and lowest quartiles of the lipoproteins and lipids, no significant difference was found (Lp(a): mean difference=0·03, P=0·67; apoA1: mean difference=0·14, P=0·04; apoB-100: mean difference=0·05, P=0·41; total cholesterol: mean difference=0·00, P=0·97; high density lipoprotein: mean difference=0·03, P=0·67; triglycerides: mean difference=0·13, P=0·05). The lipoproteins and lipids were entered in a multiple regression model together with age, gender, current smoker status, diabetes, relative gain in luminal diameter and the minimal lumen diameter post-PTCA as covariates. From the model, the plasma levels of lipoproteins and lipids were not correlated with luminal loss, but relative gain in minimal lumen diameter and relative minimal lumen diameter post-PTCA were significantly and positively correlated with relative loss (Table 4 ). Due to MLD=minimal luminal diameter; relative gain=minimal lumen diameter immediately after minus minimal lumen diameter before angioplasty, divided by the reference diameter of the vessel measured before angioplasty; relative loss=minimal lumen diameter immediately after angioplasty minus minimal lumen diameter at follow-up, divided by the reference diameter of the vessel measured before angioplasty. colinearity between relative gain and relative minimal lumen diameter post-PTCA, these variables were entered separately into the regression model.
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Relationship between restenosis and the lipoproteins and lipids
Only patients with single vessel dilatation were analysed in this part of the study. Restenosis occurred in 60 patients (23·9%) according to restenosis criteria 1 (>50% diameter stenosis at follow-up), 72 patients (28·7%) according to restenosis criteria 2 (loss of >50% of the gain) and in 46 patients (18·3%) according to restenosis criteria 3 (revascularization). No significant differences were found in the serum levels of Lp(a), apoA, apoB, high density lipoprotein, total cholesterol or triglycerides between the restenosis and no-restenosis groups according to the three restenosis definitions respectively (Table 3) . Multivariate logistic regression analysis did not identify the lipoproteins and lipids as independent risk factors for restenosis, but larger gain in minimal lumen diameter was significantly associated with reduced risk of restenosis according to criteria 2 (OR: 0·44, Cl: 0·20 to 0·95), and larger minimal lumen diameter post-PTCA was significantly associated with reduced risk of restenosis according to restenosis criteria 1 (OR: 0·29, Cl: 0·11 to 0·78), criteria 2 (OR: 0·34, Cl: 0·14 to 0·86) and criteria 3 (OR: 0·34, Cl: 0·12 to 0·98), when entered separately in regression models.
Discussion
In the present study, plasma levels of Lp(a), apoA, apoB, total cholesterol, high density lipoprotein and triglycerides were not associated with either luminal loss or restenosis. The relationship between various lipoproteins and lipids and restenosis has been widely studied, and much attention has been devoted to Lp(a) as a potential risk factor. Lp(a) is a low density lipoproteinlike substance that contains apoB, and a disulphide linked apoA moiety, which competitively inhibits binding of plasminogen in the thrombolytic system [29] . Both Lp(a) and apoA have also been shown to stimulate smooth muscle cell proliferation [30] . The relationship between Lp(a) and restenosis has been investigated in several studies with conflicting results (Table 5) , thus illustrating the difficulty in drawing conclusions as to whether Lp(a) is predictive of restenosis after balloon angioplasty, or not. In only one study comprising 138 patients was relative luminal loss used as an outcome variable [31] , and Lp(a) measured before angioplasty was not associated with relative loss or minimal lumen diameter at follow-up. However, a significant reduction in the Lp(a) concentration from before to 1 day after angioplasty was associated with relative loss, minimal lumen diameter at follow-up and restenosis. Different study design, small number of patients, incomplete reangiography, different restenosis definitions used or only one definition selected, may account for some of the discrepancies in previous studies. Angiographic restenosis as a binary definition does not reflect the biological renarrowing process occurring after angioplasty, whereas luminal loss better represents the pathological process involved [32] . The frequency distribution of Lp(a) is extremely skewed towards lower values [15, 16, 33] , thus, logarithmic transformed Lp(a) values should be used in regression analysis [34] . The picture is more unambiguous for other lipoproteins and lipids assessed as risk factors. Violaris et al. [18] Luminal loss and restenosis after angioplasty 1411 showed, in 2753 patients with 3336 lesions, no association between total cholesterol, high density lipoprotein or low density lipoprotein and relative luminal loss after angioplasty. Total cholesterol, triglycerides, high density lipoprotein, apoA and apoB assessed in another study were also not associated with restenosis [35] . We incorporated several clinical and angiographic variables for possible association with luminal loss and restenosis. Relative gain in minimal lumen diameter exerted a significant positive independent influence on relative luminal loss, and larger luminal gain was independently predictive of less restenosis (depending on the restenosis criteria used). The post-procedural minimal lumen diameter was also independently and positive correlated with loss in minimal lumen diameter, and bigger post-procedural minimal lumen diameter was also associated with less restenosis. These findings are in accordance with results from other studies [24, 25, 28, 36] , in which angiographic variables obtained immediately before and after angioplasty have been shown to be associated with luminal loss and restenosis.
Although this was a substudy of an interventional trial and lipoproteins and lipids were not assessed in all patients, the study was prospective and only consecutive patients with complete angiographic follow-up were included. The follow-up angiography was done 4 months after PTCA based on the studies by Nobuyoshi et al. and Serruys et al. [37, 38] , which demonstrated that the luminal renarrowing is a time-related phenomenon developing during the first 4 months after angioplasty. We allowed inclusion of patients on statins, since these drugs (lovastatin and pravastatin) have not been shown to reduce luminal loss, or the rate of restenosis [39, 40] , or the plasma levels of Lp(a) [41] . Recently published study, fluvastatin also failed to show an effect on luminal loss and restenosis, although pre-treatment with the study drug was done [42] , which further indicates the lack of a relationship between lipids and restenosis.
The mechanical impact of angioplasty involves different degrees of plaque and vessel wall trauma, which may modulate the elastic properties and reactive intimal hyperplasia post interventionally. Luminal loss assessed by angiography are only a part of the more complex arterial remodelling process occurring after PTCA [43] . Intravascular ultrasound examination delineates the vessel wall structure not detectable by angiography [44] . It is suggested that shrinkage of the vessel wall, adventitial thickening and only slight intimal hyperplasia are the predominant cause of post-interventional luminal loss [45] [46] [47] . It remains to be shown whether biological factors are associated with morphological changes leading to restenosis, assessed by techniques quantifying changes in the different vessel wall structures.
In conclusion, the present study revealed that lipoproteins and lipids known to be risk factors for coronary artery disease, were not associated with luminal loss post angioplasty or restenosis. However, the direct mechanical impact of the angioplasty procedure assessed as luminal gain and the post-angioplasty luminal diameter, were associated with both late loss in luminal diameter and restenosis after angioplasty.
